Jim Continenza

Eastman Kodak Co (NYSE: KODK) is trading significantly higher on above-average volume Tuesday following increasing interest from retail investors.  What Happened: In July 2020, Kodak shares surged as much as 1,900% in two days after the company was awarded a $765-million...

Eastman Kodak Co. (NYSE: KODK) shares spiked over 40% at one point on Wednesday after the company's CEO Jim Continenza announced on Twitter that Kodak is "partnering with Microsoft #Vpress and @PrintVis1 on the print industry’s first all-in-one business portfolio....

There was no wrongdoing involved in the process of Eastman Kodak Company (NYSE: KODK) receiving a $765 million federal loan for its pharmaceuticals foray, the U.S. International Development Finance Corp. has reportedly concluded.  What Happened: The DFC is the federal agency that...

Eastman Kodak Co (NYSE: KODK) CEO Jim Continenza said Monday that the company would push ahead with making generic drug ingredients, irrespective of whether it receives government assistance or not, the Wall Street Journal reports. What Happened: “It was put on hold but we are...

Eastman Kodak Company’s (NYSE: KODK) shares jumped in pre-market session Wednesday as the special committee appointed by its board declared the outcome of its independent review on the company’s handling of stock options to the CEO. What Happened: The committee remarked that...

An Eastman Kodak Co. (NYSE: KODK) board member and his wife donated nearly half their stock holding in the company, amounting to 3 million shares, to a religious charity on a day when the company’s stock hit its highest valuation since 2014, the Wall Street Journal...

The federal government is halting a $765 million loan to Eastman Kodak Company (NYSE: KODK) for its generic drug-making foray until the company is cleared of insider trading allegations. What Happened "On July 28, we signed a Letter of Interest with Eastman Kodak. Recent allegations of...

Eastman Kodak Company (NYSE: KODK) is under investigation by the United States Securities and Exchange Commission surrounding the announcement of a $765 million federal loan for its foray into pharmaceuticals last month, the Wall Street Journal reported Tuesday. What Happened The SEC...